open access

Vol 68, No 9 (2010)
Original articles
Published online: 2010-09-21
Submitted: 2012-12-28
Get Citation

Relationship between low-density lipoprotein cholesterol level on admission and in-hospital mortality in patients with ST-segment elevation myocardial infarction, with or without diabetes, treated with percutaneous coronary intervention

Damian Pres, Mariusz Gąsior, Andrzej Lekston, Marek Gierlotka, Michał Hawranek, Mateusz Tajstra, Piotr Buchta, Grzegorz Słonka, Lech Poloński
Kardiol Pol 2010;68(9):1005-1012.

open access

Vol 68, No 9 (2010)
Original articles
Published online: 2010-09-21
Submitted: 2012-12-28

Abstract


Background: Low-density lipoprotein cholesterol (LDL-C) is the independent risk factor for coronary artery disease. Diabetes mellitus (DM) is associated with poor outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary interventions (PCI). The relationship between LDL-C and mortality in patients with STEMI has not been well established.
Aim: To assess whether the LDL-C level on admission can predict in-hospital mortality in patients with or without DM treated with PCI for STEMI.
Methods: 1808 consecutive patients with STEMI (378 with DM) treated with PCI were included in the analysis. Patients were divided according to the presence of DM and LDL-C level on admission with a threshold of 3.7 mmol/L (143 mg/dL). In the diabetic group there were 208 patients with LDL-C < 3.7 mmol/L (143 mg/dL) and 170 with LDL-C ≥ 3.7 mmol/L (143 mg/dL), whereas in the non-diabetic group 726 and 704 patients, respectively. We analysed the effects of LDL-C level and various risk factors on in-hospital mortality separately for patients with or without DM.
Results: The mean total cholesterol (5.6 ± 1.4 vs 5.7 ± 1.5 mmol/L; 216.6 ± 54.1 vs 220.4 ± 58 mg/dL, p = 0.21), LDL-C (3.6 ± 1.3 vs 3.7 ± 1.5 mmol/L; 139.2 ± 50.3 vs 143.0 ± 58 mg/dL, p = 0.11) and triglyceride level (1.7 ± 0.6 vs 1.6 ± 0.5 mmol/L; 150 ± 52.9 vs 141.2 ± 44.1 mg/dL, p = 0.30) were similar in patients with or without DM, whereas HDL-C level was lower in diabetic patients (1.4 ± 0.6 vs 1.8 ± 0.5 mmol/L; 53.7 ± 23.0 vs 69 ± 19.2 mg/dL, p = 0.049). The in-hospital mortality was 6.1% and 3.2%, for patients with or without DM, respectively (p = 0.008). In the diabetic group in-hospital mortality was higher in patients with LDL-C level on admission ≥ 3.7 mmol/L (143 mg/dL) in comparison to the patients with LDL-C < 3.7 mmol/L (143 mg/dL; 7.1% vs 4.8%; p = 0.03). The multivariate analysis revealed that in diabetics an increase in LDL-C level on admission by 1 mmol/L (38.67 mg/dL) was related to a 45% increase in in-hospital mortality (OR 1.45, 95% CI 1.10–2.00, p = 0.023). In the non-diabetic group in-hospital mortality was similar in patients with LDL-C level on admission ≥ 3.7 mmol/L (143 mg/dL) and < 3.7 mmol/L (143 mg/dL); 2.6% vs 3.7%; p = 0.21. In multivariate analysis LDL-C level was not related with in-hospital mortality in patients without DM (per 1 mmol/L; 38.67 mg/dL); OR 0.95, 95% CI 0.70–1.27, p = 0.71.
Conclusions: Elevated LDL-C level on admission is associated with increased in-hospital mortality in diabetic but not in non-diabetic patients treated with PCI for STEMI.
Kardiol Pol 2010; 68, 9: 1005-1012

Abstract


Background: Low-density lipoprotein cholesterol (LDL-C) is the independent risk factor for coronary artery disease. Diabetes mellitus (DM) is associated with poor outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary interventions (PCI). The relationship between LDL-C and mortality in patients with STEMI has not been well established.
Aim: To assess whether the LDL-C level on admission can predict in-hospital mortality in patients with or without DM treated with PCI for STEMI.
Methods: 1808 consecutive patients with STEMI (378 with DM) treated with PCI were included in the analysis. Patients were divided according to the presence of DM and LDL-C level on admission with a threshold of 3.7 mmol/L (143 mg/dL). In the diabetic group there were 208 patients with LDL-C < 3.7 mmol/L (143 mg/dL) and 170 with LDL-C ≥ 3.7 mmol/L (143 mg/dL), whereas in the non-diabetic group 726 and 704 patients, respectively. We analysed the effects of LDL-C level and various risk factors on in-hospital mortality separately for patients with or without DM.
Results: The mean total cholesterol (5.6 ± 1.4 vs 5.7 ± 1.5 mmol/L; 216.6 ± 54.1 vs 220.4 ± 58 mg/dL, p = 0.21), LDL-C (3.6 ± 1.3 vs 3.7 ± 1.5 mmol/L; 139.2 ± 50.3 vs 143.0 ± 58 mg/dL, p = 0.11) and triglyceride level (1.7 ± 0.6 vs 1.6 ± 0.5 mmol/L; 150 ± 52.9 vs 141.2 ± 44.1 mg/dL, p = 0.30) were similar in patients with or without DM, whereas HDL-C level was lower in diabetic patients (1.4 ± 0.6 vs 1.8 ± 0.5 mmol/L; 53.7 ± 23.0 vs 69 ± 19.2 mg/dL, p = 0.049). The in-hospital mortality was 6.1% and 3.2%, for patients with or without DM, respectively (p = 0.008). In the diabetic group in-hospital mortality was higher in patients with LDL-C level on admission ≥ 3.7 mmol/L (143 mg/dL) in comparison to the patients with LDL-C < 3.7 mmol/L (143 mg/dL; 7.1% vs 4.8%; p = 0.03). The multivariate analysis revealed that in diabetics an increase in LDL-C level on admission by 1 mmol/L (38.67 mg/dL) was related to a 45% increase in in-hospital mortality (OR 1.45, 95% CI 1.10–2.00, p = 0.023). In the non-diabetic group in-hospital mortality was similar in patients with LDL-C level on admission ≥ 3.7 mmol/L (143 mg/dL) and < 3.7 mmol/L (143 mg/dL); 2.6% vs 3.7%; p = 0.21. In multivariate analysis LDL-C level was not related with in-hospital mortality in patients without DM (per 1 mmol/L; 38.67 mg/dL); OR 0.95, 95% CI 0.70–1.27, p = 0.71.
Conclusions: Elevated LDL-C level on admission is associated with increased in-hospital mortality in diabetic but not in non-diabetic patients treated with PCI for STEMI.
Kardiol Pol 2010; 68, 9: 1005-1012
Get Citation

Keywords

low-density lipoprotein cholesterol; myocardial infarction; diabetes mellitus

About this article
Title

Relationship between low-density lipoprotein cholesterol level on admission and in-hospital mortality in patients with ST-segment elevation myocardial infarction, with or without diabetes, treated with percutaneous coronary intervention

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 68, No 9 (2010)

Pages

1005-1012

Published online

2010-09-21

Bibliographic record

Kardiol Pol 2010;68(9):1005-1012.

Keywords

low-density lipoprotein cholesterol
myocardial infarction
diabetes mellitus

Authors

Damian Pres
Mariusz Gąsior
Andrzej Lekston
Marek Gierlotka
Michał Hawranek
Mateusz Tajstra
Piotr Buchta
Grzegorz Słonka
Lech Poloński

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl